Cost–effectiveness of artemisinin combination therapy for uncomplicated malaria in children: data from Papua New Guinea | Zendy

Wendy A. Davis | Zendy; Philip Clarke | Zendy; Peter M. Siba | Zendy; Harin Karunajeewa | Zendy; Carol Davy | Zendy; Ivo Müeller | Zendy; Timothy M. E. Davis | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Cost–effectiveness of artemisinin combination therapy for uncomplicated malaria in children: data from Papua New Guinea

Author(s) -

Wendy A. Davis,

Philip Clarke,

Peter M. Siba,

Harin Karunajeewa,

Carol Davy,

Ivo Müeller,

Timothy M. E. Davis

Publication year - 2011

Publication title -

bulletin of the world health organization

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.459

H-Index - 168

eISSN - 1564-0604

pISSN - 0042-9686

DOI - 10.2471/blt.10.084103

Subject(s) - artemisinin , malaria , medicine , artesunate , regimen , artemether , plasmodium vivax , cost effectiveness , dihydroartemisinin , sulfadoxine/pyrimethamine , sulfadoxine , piperaquine , artemether/lumefantrine , new guinea , chloroquine , plasmodium falciparum , pyrimethamine , immunology , risk analysis (engineering) , ethnology , history

To compare the cost-effectiveness of conventional antimalarial therapy with that of three artemisinin combination treatment regimens in children from Papua New Guinea aged 6 to 60 months.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research